In today’s recent session, 0.8 million shares of the Q32 Bio Inc (NASDAQ:QTTB) have been traded, and its beta is -0.48. Most recently the company’s share price was $7.92, and it changed around -$16.49 or -67.55% from the last close, which brings the market valuation of the company to $96.47M. QTTB at last check was trading at a discount to its 52-week high of $53.79, offering almost -579.17% off that amount. The share price’s 52-week low was $9.54, which indicates that the recent value has fallen by an impressive -20.45% since then. We note from Q32 Bio Inc’s average daily trading volume that its 10-day average is 0.14 million shares, with the 3-month average coming to 111.33K.
Q32 Bio Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.71. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended QTTB as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight. Q32 Bio Inc is expected to report earnings per share of 0 for the current quarter.
Q32 Bio Inc (NASDAQ:QTTB) trade information
Instantly QTTB has been showing red trend so far today with a performance of -67.55% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 28.06 on recent trading dayincreased the stock’s daily price by 71.77%. The company’s shares are currently down -27.63% year-to-date, but still down -67.61% over the last five days. On the other hand, Q32 Bio Inc (NASDAQ:QTTB) is -82.40% down in the 30-day period. We can see from the shorts that 0.72 million shares have been sold at a short interest cover period of 6.74 day(s).
The consensus price target as assigned by Wall Street analysts is $80, which translates to bulls needing to increase their stock price by 90.1% from its current value. Analyst projections state that QTTB is forecast to be at a low of $64 and a high of $95.
Q32 Bio Inc (QTTB) estimates and forecasts
Q32 Bio Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -59.18 percent over the past six months and at a 83.56% annual growth rate that is well above the industry average of 17.20%. Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -0.07%. Q32 Bio Inc earnings are expected to increase by 27.00% in 2024, but the outlook is negative -9.40% per year for the next five years.
